MOLECULAR TRANSFER, INC.
mRNA transfection reagents and protocols for directed differentiation of human pluripotent stem cells into dopaminergic neurons
- Sector
- Biotech
- Total capital
- $238K
- Federal grants
- $225K
- 1 award · 2016
- At sector median 1 award
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $13K
- 2 awards · Health and Human S
- Rank in Biotech#379 of 4373
- Granted patents
- 12
- 14 pending · first 2016
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · mRNA-Directed Differentiation of hPSC to A10 Dopaminergic Neurons$225K
- Federal contractHealth and Human S · Molecular Transfer, INC.:1218692 [13-003023]$4K
- Federal contractHealth and Human S · Mef (fibroblasts)$9K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing in Biotech · 4373 companies
Line = median- Federal contracts#379 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 12 granted of 26- PendingPlant Virus Movement Proteins And Methods Of Using SameUSPTOApplication 19026129
- PendingAgents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsUSPTOApplication 18771323
- PendingPolycationic Methyl Phospholipids For Improved Delivery Of Nucleic Acids To Eukaryotic CellsUSPTOApplication 18747146
Show all 26 patent records
- Plant Virus Movement Proteins And Methods Of Using SameMay 15, 2025 · Application 19026129Pending
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsJan 9, 2025 · Application 18771323Pending
- Polycationic Methyl Phospholipids For Improved Delivery Of Nucleic Acids To Eukaryotic CellsDec 12, 2024 · Application 18747146Pending
- Transfection Complexes And Methods Of Using The SameNov 28, 2024 · Application 18670514Pending
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsAug 20, 2024 · US 12,065,665Granted
- Pol Ycationic Methyl Phospholipids For Improved Delivery Of Nucleic Acids To Eukaryotic CellsJul 23, 2024 · US 12,043,639Granted
- Transfection Complexes And Methods Of Using The SameJul 16, 2024 · US 12,037,600Granted
- Plant Virus Movement Proteins And Methods Of Using SameJun 27, 2024 · Application 18523380Pending
- Plant Virus Movement Proteins And Methods Of Using SameJan 9, 2024 · US 11,866,723Granted
- Transfection Complexes And Methods Of Using The SameAug 10, 2021 · US 11,085,056Granted
- Polycationic Methyl Phospholipids For Improved Delivery Of Nucleic Acids To Eukaryotic CellsApr 6, 2021 · US 10,968,240Granted
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsJan 5, 2021 · US 10,883,118Granted
- Plant Virus Movement Proteins And Methods Of Using The SameJan 21, 2020 · US 10,538,784Granted
- Polycationic Methyl Phospholipids For Improved Delivery Of Nucleic Acids To Eukaryotic CellsDec 18, 2018 · US 10,155,780Granted
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsNov 27, 2018 · US 10,138,497Granted
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsSep 19, 2017 · US 9,765,359Granted
- Agents for Improved Delivery of Nucleic Acids to Eukaryotic CellsFeb 16, 2016 · US 9,259,475Granted
- Novel Lipids For Transfection Of Nucleic AcidsApplication PCTUS2004016406Pending
- Plant Virus Movement Proteins And Methods Of Using The SameApplication PCTUS2017020145Pending
- Transfection Complexes And Methods Of Using The SameApplication PCTUS2016049111Pending
- Polycationic Methyl Phospholipids For Improveddelivery Of Nucleic Acids To Eukaryotic CellsApplication PCTUS2013067157Pending
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsApplication PCTUS2012036951Pending
- Agents For Improved Delivery Of Nucleic Acids To Eukaryotic CellsApplication PCTUS2012033847Pending
- Novel Peptides For Use In TransfectionApplication PCTUS2009052425Pending
- Novel Reagents For Transfection Of Eukaryotic CellsApplication PCTUS2006019356Pending
- Ready-to-use Electroporation Cuvette Including Frozen Electrocompetent CellsApplication PCTUS2005008958Pending
Related companies, and why
- Guardant HealthSimilar federal contract value in Biotech · $14K in contracts
- PK BIOSCIENCES CORPORATIONSimilar federal contract value in Biotech · $14K in contracts
- Cellular Engineering Technologies, Inc.Similar federal contract value in Biotech · $14K in contracts
- SUPERIOR NANO LLCSimilar federal contract value in Biotech · $12K in contracts
- SPECTRAGENETICSSimilar federal contract value in Biotech · $11K in contracts
- Infinity Bio, Inc.Similar federal contract value in Biotech · $11K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .